Skip to content
  • HOME
  • ABOUT
    • ABOUT CPA
    • ADVOCACY
    • MEMBERSHIP
    • HISTORY
    • OUR MISSION
    • OUR VISION
    • CONTRIBUTE
    • CONTACT US
  • RESEARCH
    • RESEARCH HUB
    • TRADE & TARIFFS
    • CURRENCIES
    • MODELING
    • INDUSTRIAL STRATEGIES
    • LABOR & INEQUALITY
    • ECONOMICS CHARTS
    • ECONOMICS PRESENTATIONS
    • CURRENCY MISALIGNMENT MONITOR
    • DOMESTIC MARKET SHARE INDEX
    • TRADE DATABASE
  • ISSUES
    • AGRICULTURE
    • BUY AMERICAN
    • CHINA
    • CURRENCY
    • HEALTHCARE
    • MANUFACTURING
    • RENEWABLE ENERGY
    • TAX
    • TECHNOLOGY
    • TRADE & TARIFFS
  • NEWSROOM
    • THE LATEST
    • PRESS RELEASES
    • CPA OPINION
    • LETTERS & TESTIMONY
Menu
  • HOME
  • ABOUT
    • ABOUT CPA
    • ADVOCACY
    • MEMBERSHIP
    • HISTORY
    • OUR MISSION
    • OUR VISION
    • CONTRIBUTE
    • CONTACT US
  • RESEARCH
    • RESEARCH HUB
    • TRADE & TARIFFS
    • CURRENCIES
    • MODELING
    • INDUSTRIAL STRATEGIES
    • LABOR & INEQUALITY
    • ECONOMICS CHARTS
    • ECONOMICS PRESENTATIONS
    • CURRENCY MISALIGNMENT MONITOR
    • DOMESTIC MARKET SHARE INDEX
    • TRADE DATABASE
  • ISSUES
    • AGRICULTURE
    • BUY AMERICAN
    • CHINA
    • CURRENCY
    • HEALTHCARE
    • MANUFACTURING
    • RENEWABLE ENERGY
    • TAX
    • TECHNOLOGY
    • TRADE & TARIFFS
  • NEWSROOM
    • THE LATEST
    • PRESS RELEASES
    • CPA OPINION
    • LETTERS & TESTIMONY

Popular Keywords

Categories

No Record Found

View More

To Fight Drug Shortages FDA Has an Idea: Import More Inspection-Free Drugs

Archive, Commentary Featured, Featured Home Page, Healthcare, Issues, NewsroomBy Kenneth RapozaJune 2, 2023Leave a comment

The balance between scarcity and supply favors supply, even if that means importing drugs from labs the FDA has not inspected.

China’s Ever-Expanding Orwellian State is a Warning to the US – Congressional Hearing

Capital Markets, China, CPA News, Customs, Featured Home Page, Healthcare, Issues, NewsroomBy Kenneth RapozaNovember 16, 2022Leave a comment

The Congressional-Executive Commission on China hears testimony about Zero Covid and the human rights abuses its exacerbated in the world’s No. 2 economy. In a report by the Commission, calls for more capital market sanctions.

FDA Advancements Act Passes Committee, Sets Stage for Fall Reauthorization Passage

Archive, CPA News, Featured Home Page, Healthcare, Issues, Manufacturing, NewsroomBy Kenneth RapozaJune 15, 2022Leave a comment

The FDA Safety and Landmark Advancements (FDASLA) Act has passed a key committee, with 25 out of some 30 amendments passing. Generics and baby formula crisis got most of the attention.

FDA’s Updated Drug Shortage List Loaded with Critical Medicines

Archive, CPA News, Featured Home Page, Healthcare, Issues, NewsroomBy Kenneth RapozaJune 1, 2022Leave a comment

The Food and Drug Administration recently updated its drug shortage list. More than half of the updates include drugs on the essential medicines list.

Senate Puts FDA Re-authorization Deal in Jeopardy Over Infant Formula Crisis

Archive, Featured Home Page, Healthcare, Issues, Supply ChainBy Kenneth RapozaMay 26, 2022Leave a comment

Senator Burr warned the FDA that until the Senate is okay with their response to the infant formula crisis, and present a plan to prevent it in the future, the Generic Drug User Fee Authorization bill might be put on hold.

  • ABOUT
  • NEWSROOM
  • MEMBERSHIP
  • CONTACT
Facebook-f Twitter Youtube Linkedin

© 2023 COALITION FOR A PROSPEROUS AMERICA. ALL RIGHTS RESERVED.

Go to Top

⋆ ⋆ ⋆ MENU

  • HOME
  • ABOUT
    • ABOUT CPA
    • ADVOCACY
    • MEMBERSHIP
    • HISTORY
    • OUR MISSION
    • OUR VISION
    • CONTRIBUTE
    • CONTACT US
  • RESEARCH
    • RESEARCH HUB
    • TRADE & TARIFFS
    • CURRENCIES
    • MODELING
    • INDUSTRIAL STRATEGIES
    • LABOR & INEQUALITY
    • ECONOMICS CHARTS
    • ECONOMICS PRESENTATIONS
    • CURRENCY MISALIGNMENT MONITOR
    • DOMESTIC MARKET SHARE INDEX
    • TRADE DATABASE
  • ISSUES
    • AGRICULTURE
    • BUY AMERICAN
    • CHINA
    • CURRENCY
    • HEALTHCARE
    • MANUFACTURING
    • RENEWABLE ENERGY
    • TAX
    • TECHNOLOGY
    • TRADE & TARIFFS
  • NEWSROOM
    • THE LATEST
    • PRESS RELEASES
    • CPA OPINION
    • LETTERS & TESTIMONY
 Twitter
 Facebook
 LinkedIn
 Copy
 Email